These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 10411579

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Functional beta3-adrenoceptor in the human heart.
    Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H.
    J Clin Invest; 1996 Jul 15; 98(2):556-62. PubMed ID: 8755668
    [Abstract] [Full Text] [Related]

  • 3. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
    Imbrogno S, Angelone T, Adamo C, Pulerà E, Tota B, Cerra MC.
    J Exp Biol; 2006 Dec 15; 209(Pt 24):4966-73. PubMed ID: 17142685
    [Abstract] [Full Text] [Related]

  • 4. beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.
    Tavernier G, Toumaniantz G, Erfanian M, Heymann MF, Laurent K, Langin D, Gauthier C.
    Cardiovasc Res; 2003 Aug 01; 59(2):288-96. PubMed ID: 12909312
    [Abstract] [Full Text] [Related]

  • 5. [Effect of beta3-adrenoreceptors agonist on beta3-adrenoreceptors expression and myocyte apoptosis in a rat model of heart failure].
    Kong YH, Li WM, Tian Y.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar 01; 16(3):142-7. PubMed ID: 15009959
    [Abstract] [Full Text] [Related]

  • 6. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT, Li WM, Xiu CH, Shen JX, Wang X, Wu S, Kong YH.
    Chin Med J (Engl); 2007 Dec 20; 120(24):2250-5. PubMed ID: 18167212
    [Abstract] [Full Text] [Related]

  • 7. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C.
    J Am Coll Cardiol; 2009 Apr 28; 53(17):1532-8. PubMed ID: 19389564
    [Abstract] [Full Text] [Related]

  • 8. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
    Galitzky J, Langin D, Verwaerde P, Montastruc JL, Lafontan M, Berlan M.
    Br J Pharmacol; 1997 Nov 28; 122(6):1244-50. PubMed ID: 9401793
    [Abstract] [Full Text] [Related]

  • 9. Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium.
    Napp A, Brixius K, Pott C, Ziskoven C, Boelck B, Mehlhorn U, Schwinger RH, Bloch W.
    J Card Fail; 2009 Feb 28; 15(1):57-67. PubMed ID: 19181295
    [Abstract] [Full Text] [Related]

  • 10. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J, Zhang LF, Han C, Yu GS, Ma J.
    J Gravit Physiol; 1996 Apr 28; 3(1):57-62. PubMed ID: 11539308
    [Abstract] [Full Text] [Related]

  • 11. Existence of beta(3)-adrenoceptors in rat heart: functional implications.
    Barbier J, Mouas C, Rannou-Bekono F, Carré F.
    Clin Exp Pharmacol Physiol; 2007 Aug 28; 34(8):796-8. PubMed ID: 17600560
    [Abstract] [Full Text] [Related]

  • 12. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.
    Hillman KL, Doze VA, Porter JE.
    J Pharmacol Exp Ther; 2005 Aug 28; 314(2):561-7. PubMed ID: 15908513
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rabbit, a relevant model for the study of cardiac beta 3-adrenoceptors.
    Audigane L, Kerfant BG, El Harchi A, Lorenzen-Schmidt I, Toumaniantz G, Cantereau A, Potreau D, Charpentier F, Noireaud J, Gauthier C.
    Exp Physiol; 2009 Apr 28; 94(4):400-11. PubMed ID: 19151075
    [Abstract] [Full Text] [Related]

  • 16. Species-dependent differences in inotropic effects and phosphoinositide hydrolysis induced by endothelin-3 in mammalian ventricular myocardium.
    Yang HT, Zhu Y, Endoh M.
    Br J Pharmacol; 1997 Apr 28; 120(8):1497-504. PubMed ID: 9113371
    [Abstract] [Full Text] [Related]

  • 17. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
    Amour J, Loyer X, Le Guen M, Mabrouk N, David JS, Camors E, Carusio N, Vivien B, Andriantsitohaina R, Heymes C, Riou B.
    Anesthesiology; 2007 Sep 28; 107(3):452-60. PubMed ID: 17721248
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the beta-adrenoceptor subtype involved in mediation of glucose transport in L6 cells.
    Nevzorova J, Bengtsson T, Evans BA, Summers RJ.
    Br J Pharmacol; 2002 Sep 28; 137(1):9-18. PubMed ID: 12183326
    [Abstract] [Full Text] [Related]

  • 19. β3-Adrenoceptor-mediated responses in diabetic rat heart.
    Kayki-Mutlu G, Arioglu-Inan E, Ozakca I, Ozcelikay AT, Altan VM.
    Gen Physiol Biophys; 2014 Sep 28; 33(1):99-109. PubMed ID: 24334532
    [Abstract] [Full Text] [Related]

  • 20. Induction of beta3-adrenergic receptor functional expression following chronic stimulation with noradrenaline in neonatal rat cardiomyocytes.
    Germack R, Dickenson JM.
    J Pharmacol Exp Ther; 2006 Jan 28; 316(1):392-402. PubMed ID: 16183708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.